Table 2.
Patient demographics and clinical characteristics
| Pathology Tumor Tissue Dx | Plasma MV Analysis | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| # | Sex | Age | Treatment Prior to Blood Draw | Diagnosis | EGFR | EGFRvIII | IDH1-R132H | EGFR | EGFRvIII | IDH1-R132H |
| G1 | M | 49 | None | GB mesench | Amp | NA | WT | Pos | Pos | Neg |
| G2 | F | 75 | None | GB proneural | Polysomy Chr7 | NA | WT | Pos | Neg | Neg |
| G3 | M | 73 | None | GB proneural | Neg | Neg | WT | Neg | Neg | Neg |
| G4 | F | 63 | None | GB proneural | Amp | Neg | WT | Pos | Neg | Neg |
| G5 | M | 55 | Surgery + XRT + TMZ | GB mesench | Amp | Neg | WT | Pos | Neg | Neg |
| G6 | M | 61 | Surgery + XRT + TMZ | GB mesench | Amp | Neg | WT | Pos | Neg | Neg |
| G7 | M | 73 | Surgery + XRT + TMZ | GB NA | Amp | NA | WT | Pos | Neg | Neg |
| G8 | F | 54 | Surgery + XRT + TMZ | GB mesench | Neg | Neg | WT | Neg | Neg | Neg |
| H1 | M | 57 | None | Normal | NA | NA | NA | NA | NA | NA |
| H2 | M | 50 | None | Normal | NA | NA | NA | NA | NA | NA |
XRT = external beam radiation therapy; TMZ = temozolomide; WT = wildtype. The plasma MV analysis was largely concordant with pathological analysis of tumor tissue, although some specimens were small biopsies only. NA = not available.